{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T13:35:19Z","timestamp":1794490519617,"version":"4.9.1"},"reference-count":85,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Psychology Review"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.cpr.2016.10.009","type":"journal-article","created":{"date-parts":[[2016,10,28]],"date-time":"2016-10-28T01:32:48Z","timestamp":1477618368000},"page":"75-95","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":67,"special_numbering":"C","title":["A systematic review of service-user reasons for adherence and nonadherence to neuroleptic medication in psychosis"],"prefix":"10.1016","volume":"51","author":[{"given":"Miriam","family":"Wade","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Tai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Awenat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian","family":"Haddock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cpr.2016.10.009_bb0005","series-title":"Evidence-based treatments for schizophrenia: Information for families and other supporters","author":"American Psychiatric Association","year":"2006"},{"issue":"5","key":"10.1016\/j.cpr.2016.10.009_bb0010","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1600-0447.1996.tb09868.x","article-title":"Public attitude towards psychiatric treatment","volume":"94","author":"Angermeyer","year":"1996","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"10","key":"10.1016\/j.cpr.2016.10.009_bb0015","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1185\/03007995.2010.515900","article-title":"Reasons for discontinuation and continuation of antipsychotics in the treatment of schizophrenia from patient and clinician perspectives","volume":"26","author":"Ascher-Svanum","year":"2010","journal-title":"Current Medical Research and Opinion"},{"issue":"1","key":"10.1016\/j.cpr.2016.10.009_bb0020","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.schres.2011.04.030","article-title":"Adherence to antipsychotic drug treatment in early-episode schizophrenia: A six-month naturalistic follow-up study","volume":"130","author":"Baloush-Kleinman","year":"2011","journal-title":"Schizophrenia Research"},{"issue":"5","key":"10.1016\/j.cpr.2016.10.009_bb0025","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1159\/000232973","article-title":"Comparison of patient and clinician perspectives in the assessment of antipsychotic medication adherence","volume":"42","author":"Barbui","year":"2009","journal-title":"Psychopathology"},{"issue":"1","key":"10.1016\/j.cpr.2016.10.009_bb0030","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.eurpsy.2011.02.005","article-title":"Interventions to improve adherence to antipsychotic medication in patients with schizophrenia \u2013 A review of the past decade","volume":"27","author":"Barkhof","year":"2012","journal-title":"European Psychiatry"},{"issue":"5","key":"10.1016\/j.cpr.2016.10.009_bb0040","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1093\/schbul\/sbl070","article-title":"Religious beliefs in schizophrenia: Their relevance for adherence to treatment","volume":"33","author":"Borras","year":"2007","journal-title":"Schizophrenia Bulletin"},{"issue":"3","key":"10.1016\/j.cpr.2016.10.009_bb0045","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.psc.2007.04.002","article-title":"Antipsychotic medication adherence in schizophrenia","volume":"30","author":"Byerly","year":"2007","journal-title":"Psychiatric Clinics of North America"},{"key":"10.1016\/j.cpr.2016.10.009_bb0050","author":"Centre for Reviews and Dissemination"},{"issue":"3","key":"10.1016\/j.cpr.2016.10.009_bb0055","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1447-0349.2012.00864.x","article-title":"Qualitative inquiry into motivators for maintaining medication adherence among Taiwanese with schizophrenia","volume":"22","author":"Chang","year":"2013","journal-title":"International Journal of Mental Health Nursing"},{"key":"10.1016\/j.cpr.2016.10.009_bb0060","first-page":"547","article-title":"Reasons for continuing or discontinuing olanzapine in the treatment of schizophrenia from the perspectives of patients and clinicians","volume":"5","author":"Chen","year":"2011","journal-title":"Patient Preference and Adherence"},{"key":"10.1016\/j.cpr.2016.10.009_bb0065","series-title":"Understanding psychosis and schizophrenia","author":"Cooke","year":"2014"},{"key":"10.1016\/j.cpr.2016.10.009_bb0070","series-title":"Understanding biology in adult mental health. Clinical psychology bite-size (47)","author":"Coles","year":"2016"},{"issue":"4","key":"10.1016\/j.cpr.2016.10.009_bb0075","doi-asserted-by":"crossref","first-page":"455","DOI":"10.31887\/DCNS.2009.11.4\/redrake","article-title":"Shared decision making in mental health: Prospects for personalized medicine","volume":"11","author":"Drake","year":"2009","journal-title":"Dialogues in Clinical Neuroscience"},{"issue":"8","key":"10.1016\/j.cpr.2016.10.009_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4088\/JCP.v68n0801","article-title":"Longer time to antipsychotic treatment discontinuation for any cause is associated with better functional outcomes for patients with schizophrenia, schizophreniform disorder, or schizoaffective disorder","volume":"68","author":"Dunayevich","year":"2007","journal-title":"The Journal of Clinical Psychiatry"},{"issue":"5","key":"10.1016\/j.cpr.2016.10.009_bb0090","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.jpain.2013.11.005","article-title":"Clinical pain in schizophrenia: A systematic review","volume":"15","author":"Engels","year":"2014","journal-title":"The Journal of Pain"},{"key":"10.1016\/j.cpr.2016.10.009_bb0095","series-title":"Models of madness","article-title":"Listening to the voices we hear: clients' understandings of psychotic experiences","author":"Geekie","year":"2004"},{"issue":"2","key":"10.1016\/j.cpr.2016.10.009_bb0100","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3122\/jabfm.18.2.87","article-title":"Adherence to mental health treatment in a primary care clinic","volume":"18","author":"Gonzalez","year":"2005","journal-title":"The Journal of the American Board of Family Practice"},{"issue":"3","key":"10.1016\/j.cpr.2016.10.009_bb0105","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.psychres.2008.06.002","article-title":"Locus of control: Relation to schizophrenia, to recovery, and to depression and psychosis\u2014A 15-year longitudinal study","volume":"168","author":"Harrow","year":"2009","journal-title":"Psychiatry Research"},{"key":"10.1016\/j.cpr.2016.10.009_bb0110","author":"Health and Social Care Information Centre"},{"issue":"4","key":"10.1016\/j.cpr.2016.10.009_bb0115","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1177\/2045125312474019","article-title":"Medication adherence in schizophrenia: Factors influencing adherence and consequences of nonadherence, a systematic literature review","volume":"3","author":"Higashi","year":"2013","journal-title":"Therapeutic Advances in Psychopharmacology"},{"issue":"2","key":"10.1016\/j.cpr.2016.10.009_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4088\/JCP.v65n0211","article-title":"A pilot study of barriers to medication adherence in schizophrenia","volume":"65","author":"Hudson","year":"2004","journal-title":"The Journal of Clinical Psychiatry"},{"issue":"1","key":"10.1016\/j.cpr.2016.10.009_bb0125","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/01.pra.0000344917.43780.77","article-title":"Medication adherence: A review of the literature and implications for clinical practice","volume":"15","author":"Julius","year":"2009","journal-title":"Journal of Psychiatric Practice"},{"issue":"4","key":"10.1016\/j.cpr.2016.10.009_bb0130","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1093\/schbul\/sbl011","article-title":"Medication adherence in schizophrenia: Exploring patients', carers' and professionals' views","volume":"32","author":"Kikkert","year":"2006","journal-title":"Schizophrenia Bulletin"},{"issue":"11","key":"10.1016\/j.cpr.2016.10.009_bb0135","first-page":"401","article-title":"What attitudes do psychiatrists hold towards people with mental illness?","volume":"28","author":"Kingdon","year":"2004","journal-title":"The Psychiatrist"},{"issue":"1","key":"10.1016\/j.cpr.2016.10.009_bb0140","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1017\/S0033291711001103","article-title":"Subjective experience and meaning of psychoses: The German subjective sense in psychosis questionnaire (SUSE)","volume":"42","author":"Klapheck","year":"2012","journal-title":"Psychological Medicine"},{"issue":"7","key":"10.1016\/j.cpr.2016.10.009_bb0145","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.eurpsy.2004.06.031","article-title":"Impact of present and past antipsychotic side effects on attitude toward typical antipsychotic treatment and adherence","volume":"19","author":"Lambert","year":"2004","journal-title":"European Psychiatry"},{"key":"10.1016\/j.cpr.2016.10.009_bb0150","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2307\/2529310","article-title":"The measurement of observer agreement for categorical data","author":"Landis","year":"1977","journal-title":"Biometrics"},{"issue":"9831","key":"10.1016\/j.cpr.2016.10.009_bb0155","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1016\/S0140-6736(12)60239-6","article-title":"Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: A systematic review and meta-analysis","volume":"379","author":"Leucht","year":"2012","journal-title":"The Lancet"},{"issue":"12","key":"10.1016\/j.cpr.2016.10.009_bb0160","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJMoa051688","article-title":"Effectiveness of antipsychotic drugs in patients with chronic schizophrenia","volume":"353","author":"Lieberman","year":"2005","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1016\/j.cpr.2016.10.009_bb0165","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1093\/oxfordjournals.schbul.a006898","article-title":"A prospective study of factors influencing adherence to a continuous neuroleptic treatment program in schizophrenia patients during 2years","volume":"27","author":"Linden","year":"2001","journal-title":"Schizophrenia Bulletin"},{"issue":"3","key":"10.1016\/j.cpr.2016.10.009_bb0170","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1177\/0020764009105703","article-title":"Subjective and objective indicators of recovery in severe mental illness: A cross-sectional study","volume":"56","author":"Lloyd","year":"2010","journal-title":"International Journal of Social Psychiatry"},{"issue":"3","key":"10.1016\/j.cpr.2016.10.009_bb0175","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1055\/s-2003-39985","article-title":"Schizophrenic patients' subjective reasons for compliance and noncompliance with neuroleptic treatment","volume":"36","author":"L\u00f6ffler","year":"2003","journal-title":"Pharmacopsychiatry"},{"issue":"6","key":"10.1016\/j.cpr.2016.10.009_bb0180","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1034\/j.1600-0447.2003.00085.x","article-title":"Integrated care in schizophrenia: A 2-year randomized controlled study of two community-based treatment programs","volume":"107","author":"Malm","year":"2003","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"2","key":"10.1016\/j.cpr.2016.10.009_bb0185","first-page":"595","article-title":"Developing a patient interview to assess reasons for antipsychotic discontinuation or continuation in the treatment of schizophrenia","volume":"33","author":"Matza","year":"2007","journal-title":"Schizophrenia Bulletin"},{"key":"10.1016\/j.cpr.2016.10.009_bb0190","doi-asserted-by":"crossref","first-page":"521","DOI":"10.2147\/PPA.S25635","article-title":"Validation of a patient interview for assessing reasons for antipsychotic discontinuation and continuation","volume":"6","author":"Matza","year":"2012","journal-title":"Patient Preference and Adherence"},{"key":"10.1016\/j.cpr.2016.10.009_bb0195","article-title":"Compliance therapy for schizophrenia","volume":"3","author":"McIntosh","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1016\/j.cpr.2016.10.009_bb0200","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1080\/17542863.2013.783091","article-title":"Poor adherence to antipsychotics amongst schizophrenia patients in Nigeria","volume":"7","author":"Meshach","year":"2014","journal-title":"International Journal of Culture and Mental Health"},{"issue":"4","key":"10.1016\/j.cpr.2016.10.009_bb0205","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement","volume":"151","author":"Moher","year":"2009","journal-title":"Annals of Internal Medicine"},{"issue":"2","key":"10.1016\/j.cpr.2016.10.009_bb0210","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1192\/bjp.bp.112.112110","article-title":"Antipsychotics: Is it time to introduce patient choice?","volume":"201","author":"Morrison","year":"2012","journal-title":"The British Journal of Psychiatry"},{"issue":"3","key":"10.1016\/j.cpr.2016.10.009_bb0215","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.psychres.2013.05.008","article-title":"Psychosocial and neuropsychiatric predictors of subjective recovery from psychosis","volume":"208","author":"Morrison","year":"2013","journal-title":"Psychiatry Research"},{"issue":"4","key":"10.1016\/j.cpr.2016.10.009_bb0220","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1093\/schbul\/sbs005","article-title":"Beyond the usual suspects: Positive attitudes towards positive symptoms is associated with medication noncompliance in psychosis","volume":"39","author":"Moritz","year":"2013","journal-title":"Schizophrenia Bulletin"},{"issue":"11","key":"10.1016\/j.cpr.2016.10.009_bb0225","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1016\/j.euroneuro.2014.09.008","article-title":"Nonadherence to antipsychotics: The role of positive attitudes towards positive symptoms","volume":"24","author":"Moritz","year":"2014","journal-title":"European Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.cpr.2016.10.009_bb0230","doi-asserted-by":"crossref","first-page":"2","DOI":"10.4081\/mi.2009.e2","article-title":"Cure or curse? Ambivalent attitudes towards neuroleptic medication in schizophrenia and non-schizophrenia patients","volume":"1","author":"Moritz","year":"2009","journal-title":"Mental Illness"},{"key":"10.1016\/j.cpr.2016.10.009_bb0235","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.schres.2007.04.035","article-title":"Risk of discontinuation of atypical antipsychotic agents in the treatment of schizophrenia","volume":"98","author":"Mullins","year":"2008","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.cpr.2016.10.009_bb0240","series-title":"Schizophrenia: Core interventions in the treatment and management of schizophrenia in adults in primary and secondary care","author":"National Institute for Health and Clinical Excellence","year":"2010"},{"key":"10.1016\/j.cpr.2016.10.009_bb0245","series-title":"Psychosis and schizophrenia in adults: Treatment and management (clinical guideline 178)","author":"National Institute for Health and Care Excellence","year":"2014"},{"issue":"1","key":"10.1016\/j.cpr.2016.10.009_bb0250","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ijnurstu.2011.07.002","article-title":"Testing the reliability and efficiency of the pilot mixed methods appraisal tool (MMAT) for systematic mixed studies reviews","volume":"49","author":"Pace","year":"2012","journal-title":"International Journal of Nursing Studies"},{"issue":"10","key":"10.1016\/j.cpr.2016.10.009_bb0255","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.4088\/JCP.v69n1004","article-title":"A cross-sectional study of patients' perspectives on adherence to antipsychotic medication: Depot versus oral","volume":"69","author":"Patel","year":"2008","journal-title":"Journal of Clinical Psychiatry"},{"issue":"1","key":"10.1016\/j.cpr.2016.10.009_bb0260","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.schres.2005.10.016","article-title":"Predictors of antipsychotic medication adherence in patients recovering from a first psychotic episode","volume":"83","author":"Perkins","year":"2006","journal-title":"Schizophrenia Research"},{"issue":"4","key":"10.1016\/j.cpr.2016.10.009_bb0265","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.ijnurstu.2009.01.009","article-title":"A scoring system for appraising mixed methods research, and concomitantly appraising qualitative, quantitative and mixed methods primary studies in mixed studies reviews","volume":"46","author":"Pluye","year":"2009","journal-title":"International Journal of Nursing Studies"},{"key":"10.1016\/j.cpr.2016.10.009_bb0270","author":"Pluye"},{"issue":"1","key":"10.1016\/j.cpr.2016.10.009_bb0275","first-page":"47","article-title":"Guidance on the conduct of narrative synthesis in systematic reviews","volume":"15","author":"Popay","year":"2006","journal-title":"ESRC Methods Programme"},{"key":"10.1016\/j.cpr.2016.10.009_bb0280","article-title":"Factors influencing adherence to cancer treatment in older adults with cancer: A systematic review","volume":"433","author":"Puts","year":"2013","journal-title":"Annals of Oncology"},{"issue":"8","key":"10.1016\/j.cpr.2016.10.009_bb0285","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1176\/ps.2006.57.8.1170","article-title":"Agreement between patients with schizophrenia and providers on factors of antipsychotic medication adherence","volume":"57","author":"Pyne","year":"2006","journal-title":"Psychiatric Services"},{"issue":"4","key":"10.1016\/j.cpr.2016.10.009_bb0290","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/schbul\/sbn005","article-title":"Dropout rates in randomized clinical trials of antipsychotics: A meta-analysis comparing first- and secondgeneration drugs and an examination of the role of trial design features","volume":"35","author":"Rabinowitz","year":"2009","journal-title":"Schizophrenia Bulletin"},{"key":"10.1016\/j.cpr.2016.10.009_bb0295","series-title":"Models of madness","article-title":"Public beliefs about the causes of \u2018schizophrenia\u2019","author":"Read","year":"2013"},{"issue":"4","key":"10.1016\/j.cpr.2016.10.009_bb0300","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s00127-012-0570-1","article-title":"Are attitudes towards medication adherence associated with medication adherence behaviours among patients with psychosis? A systematic review and meta analysis","volume":"48","author":"Richardson","year":"2013","journal-title":"Social Psychiatry and Psychiatric Epidemiology"},{"issue":"1","key":"10.1016\/j.cpr.2016.10.009_bb0305","first-page":"11","article-title":"Medication adherence in schizophrenia","volume":"8","author":"Roberts","year":"2011","journal-title":"Drug Discovery Today: Therapeutic Strategies"},{"issue":"9","key":"10.1016\/j.cpr.2016.10.009_bb0310","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/S0277-9536(98)00209-3","article-title":"The meaning and management of neuroleptic medication: A study of patients with a diagnosis of schizophrenia","volume":"47","author":"Rogers","year":"1998","journal-title":"Social Science & Medicine"},{"issue":"3","key":"10.1016\/j.cpr.2016.10.009_bb0315","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1590\/S1516-44462005000300005","article-title":"Evaluation of the factors interfering with drug treatment compliance among Brazilian patients with schizophrenia","volume":"27","author":"Rosa","year":"2005","journal-title":"Revista Brasileira de Psiquiatria"},{"issue":"4","key":"10.1016\/j.cpr.2016.10.009_bb0320","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.apnu.2010.09.002","article-title":"Mediating role of illness representation among social support, therapeutic alliance, experience of medication side effects, and medication adherence in persons with schizophrenia","volume":"25","author":"Rungruangsiripan","year":"2011","journal-title":"Archives of Psychiatric Nursing"},{"issue":"3","key":"10.1016\/j.cpr.2016.10.009_bb0325","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.psychres.2006.12.010","article-title":"Attitudes toward medication in inpatients with schizophrenia: A cluster analytic approach","volume":"158","author":"Santone","year":"2008","journal-title":"Psychiatry Research"},{"issue":"4","key":"10.1016\/j.cpr.2016.10.009_bb0330","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3371\/CSRP.SAWE.020813","article-title":"Reasons for adherence and nonadherence: A pilot study comparing first- and multi-episode schizophrenia patients","volume":"7","author":"Sapra","year":"2014","journal-title":"Clinical Schizophrenia & Related Psychoses"},{"issue":"1","key":"10.1016\/j.cpr.2016.10.009_bb0335","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.psychres.2014.11.002","article-title":"A systematic review of factors influencing adherence to antipsychotic medication in schizophrenia-spectrum disorders","volume":"225","author":"Sendt","year":"2015","journal-title":"Psychiatry Research"},{"issue":"12","key":"10.1016\/j.cpr.2016.10.009_bb0340","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1176\/ajp.152.12.1749","article-title":"Identifying modifiable risk factors for rehospitalization: A case-control study of seriously mentally ill persons in Mississippi","volume":"152","author":"Sullivan","year":"1995","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.cpr.2016.10.009_bb0345","first-page":"95","article-title":"Nonadherence to antipsychotic treatment in patients with schizophrenic disorders","volume":"28","author":"Svestka","year":"2007","journal-title":"Neuro Endocrinology Letters"},{"issue":"4","key":"10.1016\/j.cpr.2016.10.009_bb0350","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/bsl.539","article-title":"Does fear of coercion keep people away from mental health treatment? Evidence from a survey of persons with schizophrenia and mental health professionals","volume":"21","author":"Swartz","year":"2003","journal-title":"Behavioral Sciences & the Law"},{"issue":"1","key":"10.1016\/j.cpr.2016.10.009_bb0355","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-244X-13-168","article-title":"Perspectives on reasons for non-adherence to medication in persons with schizophrenia in Ethiopia: A qualitative study of patients, caregivers and health workers","volume":"13","author":"Teferra","year":"2013","journal-title":"BMC Psychiatry"},{"issue":"8","key":"10.1016\/j.cpr.2016.10.009_bb0360","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1176\/ps.62.8.pss6208_0888","article-title":"Becoming adherent to antipsychotics: A qualitative study of treatment-experienced schizophrenia patients","volume":"62","author":"Tranulis","year":"2011","journal-title":"Psychiatric Services"},{"issue":"1","key":"10.1016\/j.cpr.2016.10.009_bb0365","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1185\/030079907X162665","article-title":"An examination of factors affecting persistence with initial antipsychotic treatment in patients with schizophrenia","volume":"23","author":"Tunis","year":"2007","journal-title":"Current Medical Research and Opinion"},{"key":"10.1016\/j.cpr.2016.10.009_bb0370","author":"United Nations Development Programme (UNDP)"},{"issue":"1","key":"10.1016\/j.cpr.2016.10.009_bb0375","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.psychres.2003.07.004","article-title":"Understanding adherence to neuroleptic treatment in schizophrenia\u0131\u0301","volume":"126","author":"Vauth","year":"2004","journal-title":"Psychiatry Research"},{"issue":"4","key":"10.1016\/j.cpr.2016.10.009_bb0380","first-page":"1","article-title":"Expert consensus panel on adherence problems in serious and persistent mental illness. The expert consensus guideline series: Adherence problems in patients with serious and persistent mental illness","volume":"70","author":"Velligan","year":"2009","journal-title":"Journal of Clinical Psychiatry"},{"issue":"1","key":"10.1016\/j.cpr.2016.10.009_bb0385","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0920-9964(02)00498-X","article-title":"Obesity as a risk factor for antipsychotic noncompliance","volume":"66","author":"Weiden","year":"2004","journal-title":"Schizophrenia Research"},{"issue":"3","key":"10.1016\/j.cpr.2016.10.009_bb0390","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1093\/schbul\/21.3.419","article-title":"Cost of relapse in schizophrenia","volume":"21","author":"Weiden","year":"1995","journal-title":"Schizophrenia Bulletin"},{"issue":"2","key":"10.1016\/j.cpr.2016.10.009_bb0395","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1093\/schbul\/20.2.297","article-title":"Rating of medication influences (ROMI) scale in schizophrenia","volume":"20","author":"Weiden","year":"1994","journal-title":"Schizophrenia Bulletin"},{"issue":"6","key":"10.1016\/j.cpr.2016.10.009_bb0400","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/00131746-200211000-00014","article-title":"Why do patients stop their antipsychotic medications? A guide for families and friends","volume":"8","author":"Weiden","year":"2002","journal-title":"Journal of Psychiatric Practice"},{"key":"10.1016\/j.cpr.2016.10.009_bb0405","first-page":"106","article-title":"Medication noncompliance in schizophrenia. Part I. Assessment","volume":"3","author":"Weiden","year":"1997","journal-title":"Journal of Practical Psychiatry and Behavioral Health"},{"key":"10.1016\/j.cpr.2016.10.009_bb0410","series-title":"Adherence to long-term therapies. Evidence for action","author":"World Health Organisation","year":"2003"},{"key":"10.1016\/j.cpr.2016.10.009_bb0415","series-title":"Schizophrenia","author":"World Health Organisation","year":"2011"},{"key":"10.1016\/j.cpr.2016.10.009_bb0420","author":"World Health Organisation"},{"issue":"1","key":"10.1016\/j.cpr.2016.10.009_bb0425","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.psychres.2004.07.014","article-title":"Prediction of medication noncompliance in outpatients with schizophrenia: 2-year follow-up study","volume":"141","author":"Yamada","year":"2006","journal-title":"Psychiatry Research"},{"key":"10.1016\/j.cpr.2016.10.009_bb0430","first-page":"633","article-title":"Factors and assessment of noncompliance of medication","volume":"28","author":"Yamada","year":"1999","journal-title":"Japanese Journal of Clinical Psychiatry"},{"issue":"10","key":"10.1016\/j.cpr.2016.10.009_bb0435","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1176\/appi.ajp.159.10.1653","article-title":"Interventions to improve medication adherence in schizophrenia","volume":"159","author":"Zygmunt","year":"2002","journal-title":"American Journal of Psychiatry"}],"container-title":["Clinical Psychology Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272735816302288?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272735816302288?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T04:24:49Z","timestamp":1759465489000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272735816302288"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":85,"alternative-id":["S0272735816302288"],"URL":"https:\/\/doi.org\/10.1016\/j.cpr.2016.10.009","relation":{},"ISSN":["0272-7358"],"issn-type":[{"value":"0272-7358","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A systematic review of service-user reasons for adherence and nonadherence to neuroleptic medication in psychosis","name":"articletitle","label":"Article Title"},{"value":"Clinical Psychology Review","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpr.2016.10.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}